Skip to main content
Log in

Innovative Quality by Design Approach for Development of Green Micellar HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

The combined implementation of quality by design principles and green analytical chemistry leads to development of green micellar HPLC method for analysis of atorvastatin calcium and amlodipine besylate in binary mixtures and in their tablet dosage forms within 8 min. A two-level fractional factorial design was implemented for screening of different method parameters affecting chromatographic responses. Box–Behnken design was then used to study and optimize the most critical parameters. The optimum chromatographic conditions obtained from Box–Behnken design involved the use of a mixture of 0.17 M sodium dodecyl sulfate solution adjusted to pH 2.9 and 10%v/v n-butanol as mobile phase at a flow rate of 1.5 mL min−1 and column temperature kept at 45 ºC. The stationary phase was X-Bridge™ (150 mm × 4.6 mm, 5 μm) column. The fluorescence detection was programmed at 276/378 nm (excitation/ emission) for the first 5 mins for atorvastatin then switched to 366/442 nm (excitation/emission) for amlodipine. A linear response was obtained over the ranges of 0.2–25 μg mL−1 for both drugs. The proposed method was validated and successfully implemented for the simultaneous determination of cited drugs in their different tablet dosage forms. The method was additionally applied to content uniformity testing according to the official guidelines. The application of quality by design principles and green analytical chemistry results in development of robust green method with less trial and error experiments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Namieśnik J (2000) Trends in environmental analytics and monitoring. Crit Rev Anal Chem 30(2–3):221–269. https://doi.org/10.1080/10408340091164243

    Article  Google Scholar 

  2. Berthod A, Garcia-Alvarez-Coque C (2000) Micellar liquid chromatography. CRC Press, Boca Raton

    Book  Google Scholar 

  3. Ruiz-Angel M, Carda-Broch S, Torres-Lapasió JR, García-Álvarez-Coque M (2009) Retention mechanisms in micellar liquid chromatography. J Chromatogr A 1216(10):1798–1814. https://doi.org/10.1016/j.chroma.2008.09.053

    Article  CAS  PubMed  Google Scholar 

  4. Keith LH, Gron LU, Young JL (2007) Green analytical methodologies. Chem Rev 107:2695–2708. https://doi.org/10.1021/cr068359e

    Article  CAS  PubMed  Google Scholar 

  5. Gałuszka A, Migaszewski ZM, Konieczka P, Namieśnik J (2012) Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trend Anal Chem 37:61–72. https://doi.org/10.1016/j.trac.2012.03.013

    Article  CAS  Google Scholar 

  6. Gaber Y, Törnvall U, Kumar M, Amin MA, Hatti-Kaul R (2011) HPLC-EAT (Environmental Assessment Tool): a tool for profiling safety, health and environmental impacts of liquid chromatography methods. Green Chem 13(8):2021–2025. https://doi.org/10.1039/C0GC00667J

    Article  CAS  Google Scholar 

  7. Capello C, Hellweg S, Badertscher B, Betschart H, Hungerbühler K (2007) Environmental assessment of waste-solvent treatment options—part 1: the ecosolvent tool—environmental assessment of waste-solvent treatment options. J Ind Ecol 11:26–38. https://doi.org/10.1021/es2001248

    Article  CAS  Google Scholar 

  8. Płotka-Wasylka J (2018) A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta 181:204–209. https://doi.org/10.1016/j.talanta.2018.01.013

    Article  CAS  PubMed  Google Scholar 

  9. Harang V, Westerlund D (1999) Optimization of an HPLC method for the separation of erythromycin and related compounds using factorial design. Chromatographia 50(9–10):525–531

    Article  CAS  Google Scholar 

  10. Talebianpoor M, Khodadoust S, Rozbehi A, Toori MA, Zoladl M, Ghaedi M, Mohammadi R, Hosseinzadeh A (2014) Application of optimized dispersive liquid–liquid microextraction for determination of melatonin by HPLC–UV in plasma samples. J Chromatogr B 960:1–7. https://doi.org/10.1016/j.jchromb.2014.04.013

    Article  CAS  Google Scholar 

  11. Nemutlu E, Kır S, Katlan D, Beksac MS (2009) Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta 80(1):117–126. https://doi.org/10.1016/j.talanta.2009.06.034

    Article  CAS  PubMed  Google Scholar 

  12. Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R (2011) Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr Sci 49(6):439–446

    Article  CAS  Google Scholar 

  13. Garg NK, Sharma G, Singh B, Nirbhavane P, Katare OP (2015) Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. J Liq Chromatogr R T 38(17):1629–1637. https://doi.org/10.1080/10826076.2015.1087409

    Article  CAS  Google Scholar 

  14. Habib AA, Mabrouk MM, Hammad SF, Megahed SM (1981) Implementation of factorial design for optimization of forced degradation conditions and development of validated stability indicating RP-HPLC method for Lidocaine hydrochloride. Der Pharma Chem 7:198–211

    Google Scholar 

  15. Candioti LV, De Zan MM, Camara MS, Goicoechea HC (2014) Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta 124:123–138. https://doi.org/10.1016/j.talanta.2014.01.034

    Article  CAS  PubMed  Google Scholar 

  16. Moffat AC, Osselton MD, Widdop B, Watts J (2011) Clarke's analysis of drugs and poisons, vol 3. Pharmaceutical press, London

    Google Scholar 

  17. Sweetman SC (2011) Martindale: the complete drug reference. Drug monographs. Pharmaceutical Press, London

    Google Scholar 

  18. Bashir S, Sherwani MUIK, Shabbir I, Batool A (2011) Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia. J Ayub Med Coll 23(3):97–100

    Google Scholar 

  19. Jani D, Shetty S, Ahmed M, Sridhar B, Shah J (2010) Simultaneous spectrophotometric estimation of atorvastatin calcium and amlodipine besylate in combined tablet dosage form by first order derivative method. Int J Chem Sci 8(1):306–314

    CAS  Google Scholar 

  20. Darwish HW, Hassan SA, Salem MY, El-Zeiny BA (2011) Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin. Spectrochim Acta A 83(1):140–148. https://doi.org/10.1016/j.saa.2011.08.005

    Article  CAS  Google Scholar 

  21. Kumbhar ST, Jadhav SD, Bhatia NM, Bhatia MS (2011) Development and validation of derivative spectrophotometric method for estimation of atorvastatin calcium and amlodipine besylate in tablet dosage form. Int J Pharm Pharm Sci 3(4):195–197

    CAS  Google Scholar 

  22. Sarrafi AH, Konoz E, Ghiyasvand M (2011) Simultaneous detemination of atorvastatin calcium and amlodipine besylate by spectrophotometry and multivariate calibration methods in pharmaceutical formulations. J Chem-NY 8(4):1670–1679

    CAS  Google Scholar 

  23. Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2016) Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products. Spectrochim Acta A 154:58–66. https://doi.org/10.1016/j.saa.2015.10.007

    Article  CAS  Google Scholar 

  24. Ibrahim N, Rizk M, Ibrahim A, Tawakkol S, Ali I (2014) Simultaneous determination of amlodipine besylate and atorvastatin calcium by using spectrophotometric method with multivariate calibration and hplc method implementing “design of experiment. Int J Pharm 6(1):419–425

    Google Scholar 

  25. Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2013) Three different methods for determination of binary mixture of amlodipine and atorvastatin using dual wavelength spectrophotometry. Spectrochim Acta A 104:70–76. https://doi.org/10.1016/j.saa.2012.11.079

    Article  CAS  Google Scholar 

  26. Darwish HW, Hassan SA, Salem MY, El-Zeany BA (2013) Development and validation of H-point standard addition method applied for the analysis of binary mixture of amlodipine and atorvastatin. Int J Pharm Bio Sci 4:230–243

    CAS  Google Scholar 

  27. Moussa BA, El-Zaher AA, Mahrouse MA, Ahmed MS (2013) Simultaneous determination of amlodipine besylate and atorvastatin calcium in binary mixture by spectrofluorimetry and HPLC coupled with fluorescence detection. Anal Chem Insights. https://doi.org/10.4137/ACI.S12921

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nasr JJ, Shalan S (2020) Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis. Spectrochim Acta A 224:117430. https://doi.org/10.1016/j.saa.2019.117430

    Article  CAS  Google Scholar 

  29. Vonica-Gligor AL, Casian T, Reznek A, Gligor F (2015) Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry. Farmacia 63:381–387

    CAS  Google Scholar 

  30. Chaudhari BG, Patel NM, Shah PB (2007) Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem Pharm Bull 55(2):241–246. https://doi.org/10.1248/cpb.55.241

    Article  CAS  PubMed  Google Scholar 

  31. Shah D, Bhatt K, Mehta R, Baldania S, Gandhi T (2008) Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations. Indian J Pharm Sci 70(6):754. https://doi.org/10.4103/0250-474X.49117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sharma AK, Dharamsi A (2012) Development and validation of RP-HPLC and spectrophotometric method for simultaneous estimation of atorvastatin and amlodipine in pharmaceutical dosage forms. Int J Pharm 3:1202–1207

    CAS  Google Scholar 

  33. Acharjya SK, Annapurna MM, Koya S (2010) Liquid chromatographic method for simultaneous estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical dosage forms. IJPBS 1:161–170

    CAS  Google Scholar 

  34. Yacoub M, Alawi M, Arafat T (2013) Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC–MS/MS. J Chromatogr B917:36–47. https://doi.org/10.1016/j.jchromb.2013.01.001

    Article  CAS  Google Scholar 

  35. Liu W, Zhang Q (2010) Determination of amlodipine besylate and atorvastatin calcium in human plasma by LC-MS/MS. Herald Med 6:301–312

    Google Scholar 

  36. Haritha P, Rao BS, Sunandamma Y (2014) Method development and validation for simultaneous determination of Amlodipine besylate and atorvastatin calcium by RP-HPLC technique. Asian J Res Chem 4:438–445

    Google Scholar 

  37. Zhou Y, Li J, He X, Jia M, Liu M, Li H, Xiong Z, Fan Y, Li W (2013) Development and validation of a liquid chromatography–tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study. J Pharm Biomed Anal 83:101–107. https://doi.org/10.1016/j.jpba.2013.04.021

    Article  CAS  PubMed  Google Scholar 

  38. Patel VB, Sahu R, Patel BM (2011) Simultaneous determination of amlodipine besylate and atorvastatin calcium in pharmaceutical tablet formulation by high performance thin layer chromatographic method. Int J Chem Tech Res 3(2):695–698. https://doi.org/10.1002/jssc.200700148

    Article  CAS  Google Scholar 

  39. Hassan SA, Elzanfaly ES, El-Zeany SBA, Salem MY (2016) Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets. Acta Pharma 66(4):479–490. https://doi.org/10.1515/acph-2016-0040

    Article  CAS  Google Scholar 

  40. Hefnawy MM, Sultan M, Al-Johar H (2009) Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations. J Liq Chromatogr Relat Technol 32(20):2923–2942. https://doi.org/10.1080/10826070903320681

    Article  CAS  Google Scholar 

  41. Dogan-Topal B, Bozal B, Demircigil BT, Uslu B, Ozkan SA (2009) Electroanalytical studies and simultaneous determination of amlodipine besylate and atorvastatine calcium in binary mixtures using first derivative of the ratio-voltammetric methods. Electroanalysis 21(22):2427–2439. https://doi.org/10.1002/elan.200904689

    Article  CAS  Google Scholar 

  42. Mohammadi A, Moghaddam AB, Eilkhanizadeh K, Alikhani E, Mozaffari S, Yavari T (2013) Electro-oxidation and simultaneous determination of amlodipine and atorvastatin in commercial tablets using carbon nanotube modified electrode. Micro Nano Lett 8:413–417. https://doi.org/10.1049/mnl.2013.0080

    Article  CAS  Google Scholar 

  43. Sivakumar T, Manavalan R, Muralidharan C, Valliappan K (2007) An improved HPLC method with the aid of a chemometric protocol: simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulations. J Sep Sci 30(18):3143–3153

    Article  CAS  Google Scholar 

  44. Koller G, Fischer U, Hungerbühler K (2000) Assessing safety, health, and environmental impact early during process development. Ind Eng Chem 39(4):960–972. https://doi.org/10.1021/ie990669i

    Article  CAS  Google Scholar 

  45. International Conference on Harmonization (ICH) (2005) ICH Harmonised tripartite guideline: Validation of analytical procedures: text and methodology Q2 (R1)

  46. The United States Pharmacopeia, USP 40, Online version, 2017, US Pharmacopeial Convention, Rockville. (https://www.uspnf.com), Accessed 25 Mar 2020

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Safa M. Megahed.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Habib, A.A., Hammad, S.F., Megahed, S.M. et al. Innovative Quality by Design Approach for Development of Green Micellar HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine. Chromatographia 83, 1221–1231 (2020). https://doi.org/10.1007/s10337-020-03937-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-020-03937-5

Keywords

Navigation